IOVANCE BIOTHERAPEUTICS, INC. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2019-12-31: Preferred Stock, Shares Authorized 50.00M shares.
- 2016-03-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 1.69K shares.
- 2015-12-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 1.69K shares.
- 2015-09-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 3.69K shares.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding |
|---|---|---|---|---|---|
| 2019-12-31 | 50.00M shares 10-K · filed 2020-02-25 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 10-Q · filed 2016-05-09 | 50.00M shares 10-Q · filed 2016-05-09 | 1.69K shares 10-Q · filed 2016-05-09 | 1.69K shares 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 10-Q · filed 2016-05-09 | 50.00M shares 10-Q · filed 2016-05-09 | 1.69K shares 10-Q · filed 2016-05-09 | 1.69K shares 10-Q · filed 2016-05-09 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | 50.00M shares 10-Q · filed 2015-11-06 | 3.69K shares 10-Q · filed 2015-11-06 | 3.69K shares 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | 50.00M shares 10-Q · filed 2015-08-10 | 3.69K shares 10-Q · filed 2015-08-10 | 3.69K shares 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.00 10-Q · filed 2015-05-11 | $0.00 10-Q · filed 2015-05-11 | 50.00M shares 10-Q · filed 2015-05-11 | 3.69K shares 10-Q · filed 2015-05-11 | 3.69K shares 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 | $0.00 10-K · filed 2016-03-11 | 50.00M shares 10-K · filed 2016-03-11 | 5.69K shares 10-K · filed 2016-03-11 | 5.69K shares 10-K · filed 2016-03-11 |
| 2014-09-30 | $6.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | 50.00M shares 10-Q · filed 2014-11-13 | 5.69K shares 10-Q · filed 2014-11-13 | 5.69K shares 10-Q · filed 2014-11-13 |
| 2014-06-30 | $6.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | 50.00M shares 10-Q · filed 2014-08-08 | 5.80K shares 10-Q · filed 2014-08-08 | 5.80K shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | $13.00 10-Q · filed 2014-05-14 | $0.00 10-Q · filed 2014-05-14 | 50.00M shares 10-Q · filed 2014-05-14 | 13.30K shares 10-Q · filed 2014-05-14 | 13.30K shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | $17.00 10-K · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | 50.00M shares 10-K · filed 2015-03-16 | 17.00K shares 10-K · filed 2015-03-16 | 17.00K shares 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | 50.00M shares 10-Q · filed 2013-11-14 | 0.00 shares 10-Q · filed 2013-11-14 | 0.00 shares 10-Q · filed 2013-11-14 | |
| 2013-09-26 | $0.00 10-K · filed 2016-03-11 | 50.00M shares 10-K · filed 2016-03-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 | 50.00M shares 10-K · filed 2014-03-28 | 0.00 shares 10-K · filed 2014-03-28 | 0.00 shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |